Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+204524Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+245620Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+247214Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+268974Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+277811Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+320752Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+352534Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+362659Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+366077Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+369396Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+399640Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+414447Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+419692Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+501100Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+514488Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+574173Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+618545Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+633552Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+668226Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+770343Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+807998Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+827098Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+858309Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+1040706Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+1204269Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+1736243Peak area normalizedmale Diabetic Neuropathy

Return to search page
  logo